In order to detect whether MEF2C expression was changed and analyze the correlation between MEF2C and Aβ levels, we used immunohistochemical analysis to detect the expressions of MEF2C and Aβ in the brains of AD patients. Here, MEF2C is linked to Alzheimer disease.